InVivo Therapeutics Holdings recetnly announced that the company would be partnering with baseball team New York Mets to promote Spinal Cord Injury (SCI) Awareness Day. The event will be held on Sunday, September 15th at Citi Field, in a game featuring the Mets taking on the Miami Marlins. The game will be played at 1:10 p.m. ET; this is the first such event held by the MLB.
Founded in 2005, InVivo is a Cambridge, MA-based company focused on developing technology using polymers to assist patients who are paralyzed from spinal cord injury. InVivo was founded by Robert S. Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. The company won the 2011 David F. Apple Award for its outstanding contribution to spinal cord injury medicine.
InVivo will be taking donations on-field for the Greater New York Chapter of the National Spinal Cord Injury Association (NSCIA), with the check presentation occurring before the game. A PSA as well as footage of the check presentation will take place during the game. The company has also donated Modell’s Clubhouse to the NSCIA, allowing fans with SCI a field-level experience.
“The New York Mets have gone overboard to make sure this first SCI Awareness Day at Citi Field will be amazing,” said InVivo CEO Frank Reynolds. “We have donated more than a hundred tickets for people in chairs to experience the Mets from the field, and we expect the day to not only lead to a Mets win, but to a real uplifting of the human spirit as SCI patients and families get to experience the understanding of New York Mets fans.”
For more information, visit www.invivotherapeutics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
